DiaMedica Therapeutics Return On Equity History
| DMAC Stock | USD 6.32 -0.21 -3.22% |
Return On Equity | First Reported 2010-12-31 | Previous Quarter -0.58 | Current Value -0.58 | Quarterly Volatility 2.2 |
Macro event markers
Latest DiaMedica Therapeutics Return On Equity Growth Pattern
| Return On Equity | 10 Years Trend |
|
Return On Equity |
| Timeline |
Return On Equity Trend Statistics
Across 15 reporting periods, DiaMedica Therapeutics' Return On Equity registers a CV of 205.0%, signaling elevated dispersion relative to the mean. The linear fit (R² = 0.03) suggests no statistically meaningful linear trend.| Arithmetic Mean | -1.07 | |
| Geometric Mean | 1.02 | |
| Coefficient Of Variation | -205.03 (interpretation is limited given the negative mean) | |
| Mean Deviation | 1.53 | |
| Median | -0.58 | |
| Standard Deviation | 2.20 | |
| Sample Variance | 4.83 | |
| Range | 8.5151 | |
| R-Value | 0.17 | |
| Mean Square Error | 5.01 | |
| R-Squared | 0.03 | |
| Significance | 0.52 | |
| Slope | 0.07 | |
| Total Sum of Squares | 77.24 |
DiaMedica Therapeutics Return On Equity History
The table below covers 15 reported values for DiaMedica Therapeutics' Return On Equity, from -4 (2012) to -1 (2026).| 2026 | -0.61 | ||
| 2025 | -0.58 | ||
| 2024 | -0.6 | ||
| 2023 | -0.38 | ||
| 2022 | -0.43 | ||
| 2021 | -0.31 | ||
| 2020 | -0.47 | ||
| 2019 | -1.4 | ||
| 2018 | -0.34 | ||
| 2017 | -5.33 | ||
| 2016 | -1.78 | ||
| 2015 | 1.17 | ||
| 2014 | 3.15 | ||
| 2013 | -5.36 | ||
| 2012 | -4.44 |
Correlation of Return On Equity With Other Accounts
Correlation values indicate the degree of linear co-movement between DiaMedica Therapeutics' Return On Equity and other reported accounts. Values near +1 or −1 suggest strong association; values near 0 suggest independence. These relationships are descriptive and do not imply causation.Click cells to compare fundamentals
Related Fundamentals
| Last Reported | End Of Year Estimate | ||
| Return On Tangible Assets | -0.53 | -0.56 | |
| Return On Capital Employed | -0.61 | -0.64 | |
| Return On Assets | -53.00% | -56.00% |
Methodology, Assumptions & Data Sources
The series below tracks DiaMedica Therapeutics's Return On Equity across available reporting periods. Sequential period comparisons surface inflection points that rolling averages can obscure. As a technology-driven company, DiaMedica Therapeutics' Return On Equity reflects ownership capital supporting the operating base.
DiaMedica Therapeutics metrics are compiled from periodic company reporting and market reference feeds and normalized before display. Reference data and historical patterns are presented and do not constitute an investment recommendation or advice.
Editorial review and methodology oversight provided by: Ellen Johnson, Member of Macroaxis Editorial Board